Other
Cerebrovascular Event
0
Pipeline Programs↗
5
Active Trials↗
0
Companies Involved↗
Cerebrovascular Event is an early-stage landscape with 0 programs across 0 companies.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
16
clinical trials
Completed9 · 56%
Recruiting5 · 31%
Unknown status2 · 13%
Clinical Trials
Trial Activity
16 trials
Tenecteplase Reperfusion Therapy in Acute Ischemic Cerebrovascular Events-BEYOND
Recruiting·—·Phase 3·NCT06954155·330 enrolled
Atorvastatin Pretreatment in Cerebrovascular Events (APICES) After Flow Diverter Implantation
Recruiting·—·Phase 4·NCT06308952·354 enrolled
Tirofiban for Patients With intraCranial Artery Stenosis and High-risk Acute Non-disabling Cerebrovascular Events(CHANCE-4）
Recruiting·—·Phase 3·NCT06319846·4,674 enrolled
Teneteplase Reperfusion Therapy in Acute Ischemic Cerebrovascular Events-Ⅳ
Recruiting·—·Phase 3·NCT06414499·1,386 enrolled
Shuxuetong for Prevention of Recurrence in Acute Cerebrovascular Events With Embolism
Completed·—·Phase 4·NCT03090113·2,416 enrolled
Clopidogrel With Aspirin in High-risk Patients With Acute Non-disabling Cerebrovascular Events II
Completed·—·Phase 3·NCT04078737·6,412 enrolled
Tenecteplase Reperfusion Therapy in Acute Ischaemic Cerebrovascular Events-5
Completed·—·Phase 3·NCT06196320·452 enrolled
ProUrokinase for Mild Ischemic Cerebrovascular Events (PUMICE)
Completed·—·Phase 3·NCT05507645·1,446 enrolled
Clopidogrel in High-risk Patients With Acute Non-disabling Cerebrovascular Events
Completed·—·Phase 3·NCT00979589·5,100 enrolled
Tenecteplase Reperfusion Therapy in Acute Ischemic Cerebrovascular Events(TRACE)
Completed·—·Phase 2·NCT04676659·240 enrolled
Platelet Reactivity in Acute Non-disabling Cerebrovascular Events
Completed·—·Phase 2/3·NCT02506140·675 enrolled
Teneteplase Reperfusion Therapy in Acute Ischemic Cerebrovascular Events-III
Completed·—·Phase 3·NCT05141305·516 enrolled
Tenecteplase Reperfusion Therapy in Acute Ischemic Cerebrovascular Events-Ⅱ
Completed·—·Phase 3·NCT04797013·1,430 enrolled
Page 1 of 2
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)